Pharminent

Abarca Health And Biogen Announces Innovative Value-Based Contract For Multiple Sclerosis Therapies

SAN JUAN, Puerto Rico, July 27, 2017 /PRNewswire/ — Abarca Health, a pharmacy benefit management (PBM) and technology company that serves more than two million lives across the nation, has signed a value-based reimbursement contract with Biogen Inc. (NASDAQ: BIIB) for select products in… http://www.prnewswire.com/news-releases/abarca-health-and-biogen-announces-innovative-value-based-contract-for-multiple-sclerosis-therapies-300495565.html

Filed under: MS